Last updated on November 2019

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis


Brief description of study

The primary objective of this study is to evaluate whether obeticholic acid (OCA; INT-747) can lead to histological improvement in fibrosis with no worsening of NASH in adults with compensated cirrhosis due to NASH.

Clinical Study Identifier: NCT03439254

Find a site near you

Start Over

Austin Health

Heidelberg, Australia
3.44miles
  Connect »

St Vincent's Hospital

Fitzroy, Australia
4.05miles
  Connect »

Royal Melbourne Hospital

Parkville, Australia
4.79miles
  Connect »

Box Hill Hospital

Box Hill, Australia
8.42miles
  Connect »